The market for corporate deals, whether M&A or going private transactions, remains relatively robust (at least compared to what it was a few years ago). Such transactions trigger fiduciary obligations of directors, officers, and at times, stockholders, and are often magnets for lawsuits. Join Roger Lane, Courtney Worcester and Michael Thompson as they provide an update on the courts' current views of various deal terms, thoughts on the recent use of intervening event clauses (aka, a buyer’s MAC), the implications for boards in deals with such clauses, as well as a discussion of the unique challenges faced by boards contemplating transactions with their major stockholders.